Marty Hinz, MD has published a number of breakthrough papers over the past several years on Parkinson’s disease (PD). However, this research has potential implication well beyond those that suffer from PD. (more…)
There are two broad classes of people when it comes to neurotransmitter-based disorders: those that are serotonin dominant and those that are dopamine dominant (there is a third class, albeit small, which is often referred to as a ‘hybrid’, meaning that these people need a great deal of support for both the serotonin and catecholamine systems). (more…)
Part 1 of this series described what is occurring if someone is shown to have dopamine fluctuations on urinary lab testing. This post will describe the clinical implications of these dopamine fluctuations and how they can be properly managed. (more…)
It can be very confusing and concerning for a person to get a test back with a “Critical High” or some correspondingly high number reported for their dopamine value. Often times, this represents what is called a “dopamine fluctuation” and is actually a sign that something is stealing dopamine away from neurotransmitter synthesis that must be corrected. (more…)
Taking powders multiple times daily can be difficult, especially if/when one of those powders tastes a lot like pulverized chalk (i.e., tyrosine). We have hundreds of clients taking D5 Mucuna 40% powder and/or tyrosine (some at very high doses – 60+ grams of D5 Mucuna 40% and 10-12 Tbsp tyrosine powder daily) anywhere from three to six or more times daily. Several months ago we asked our clients how they mixed/took their powders; here is a compilation of their responses: (more…)
